These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 1742504

  • 21. Rheumatologists' adherence to guidelines for misoprostol use in patients at high risk for nonsteroidal antiinflammatory drug gastropathy.
    Cibere J, Sibley JT, Haga M.
    J Rheumatol; 2002 Feb; 29(2):339-46. PubMed ID: 11838854
    [Abstract] [Full Text] [Related]

  • 22. Misoprostol heals gastroduodenal injury in patients with rheumatoid arthritis receiving aspirin.
    Roth S, Agrawal N, Mahowald M, Montoya H, Robbins D, Miller S, Nutting E, Woods E, Crager M, Nissen C.
    Arch Intern Med; 1989 Apr; 149(4):775-9. PubMed ID: 2495779
    [Abstract] [Full Text] [Related]

  • 23. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study.
    Raskin JB, White RH, Jaszewski R, Korsten MA, Schubert TT, Fort JG.
    Am J Gastroenterol; 1996 Feb; 91(2):223-7. PubMed ID: 8607484
    [Abstract] [Full Text] [Related]

  • 24. Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis.
    Goldstein JL, Correa P, Zhao WW, Burr AM, Hubbard RC, Verburg KM, Geis GS.
    Am J Gastroenterol; 2001 Apr; 96(4):1019-27. PubMed ID: 11316141
    [Abstract] [Full Text] [Related]

  • 25. The prevention of chronic NSAID induced upper gastrointestinal toxicity: a Cochrane collaboration metaanalysis of randomized controlled trials.
    Rostom A, Wells G, Tugwell P, Welch V, Dubé C, McGowan J.
    J Rheumatol; 2000 Sep; 27(9):2203-14. PubMed ID: 10990235
    [Abstract] [Full Text] [Related]

  • 26. Efficacy of misoprostol in upper gastro-intestinal lesions in arthritic patients on non-steroidal anti-inflammatory drugs (NSAIDS)--an Indian experience.
    Bhatt CB, Pipalia DH, Naik SR, Tilve GH.
    J Postgrad Med; 1988 Oct; 34(4):224-8. PubMed ID: 3151214
    [No Abstract] [Full Text] [Related]

  • 27. Multicenter clinical trial of zinc acexamate in the prevention of nonsteroidal antiinflammatory drug induced gastroenteropathy. Spanish Study Group on NSAID Induced Gastroenteropathy Prevention.
    Rodríguez de la Serna A, Díaz-Rubio M.
    J Rheumatol; 1994 May; 21(5):927-33. PubMed ID: 8064736
    [Abstract] [Full Text] [Related]

  • 28. New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis.
    Hochberg MC.
    Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):4-14. PubMed ID: 12528069
    [Abstract] [Full Text] [Related]

  • 29. Prevention of gastroduodenal damage with omeprazole in patients receiving continuous NSAIDs treatment. A double blind placebo controlled study.
    Bianchi Porro G, Lazzaroni M, Petrillo M, Manzionna G, Montrone F, Caruso I.
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):43-7. PubMed ID: 9615264
    [Abstract] [Full Text] [Related]

  • 30. [Sulglicotide in the prevention of gastric disease induced by NSAID. Double-blind controlled study versus placebo].
    Magarò M, Altomonte L, Zoli A, Mirone L, Wielmarin A, Massari M, Destito G, Nazzari M, Psilogenis M.
    Minerva Dietol Gastroenterol; 1989 Feb; 35(1):27-30. PubMed ID: 2725926
    [Abstract] [Full Text] [Related]

  • 31. Protective effects of prostaglandins against nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury.
    Dajani EZ, Agrawal NM.
    Int J Clin Pharmacol Res; 1989 Feb; 9(6):359-69. PubMed ID: 2699464
    [Abstract] [Full Text] [Related]

  • 32. [Ranitidine in the therapy and prevention of NSAR-induced (non-steroidal anti-rheumatic agents) gastroduodenal lesions in patients with rheumatism].
    Simon B, Bergdolt H, Dammann H, Müller P.
    Z Gastroenterol; 1991 May; 29(5):217-21. PubMed ID: 1950028
    [Abstract] [Full Text] [Related]

  • 33. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC, Burke TA, Dieleman JP, Tangelder MJ, Lee F, Goldstein JL.
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [Abstract] [Full Text] [Related]

  • 34. Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol.
    Koch M.
    Ital J Gastroenterol Hepatol; 1999 Nov; 31 Suppl 1():S54-62. PubMed ID: 10379471
    [Abstract] [Full Text] [Related]

  • 35. [Nizatidine in therapy and prevention of non-steroidal anti-rheumatic drug-induced ulcers in rheumatic patients].
    Simon B, Leucht U, Amon I, Brandau J, Müller P.
    Z Gastroenterol; 1993 Jun; 31(6):395-400. PubMed ID: 8212757
    [Abstract] [Full Text] [Related]

  • 36. Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials.
    Koch M, Dezi A, Ferrario F, Capurso I.
    Arch Intern Med; 1996 Nov 11; 156(20):2321-32. PubMed ID: 8911239
    [Abstract] [Full Text] [Related]

  • 37. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
    Goldstein JL, Aisenberg J, Lanza F, Schwartz H, Sands GH, Berger MF, Pan S.
    Clin Ther; 2006 Mar 11; 28(3):340-51. PubMed ID: 16750449
    [Abstract] [Full Text] [Related]

  • 38. A double-blind, placebo-controlled, 6-day evaluation of two doses of misoprostol in gastroduodenal mucosal protection against damage from aspirin and effect on bowel habits.
    Lanza FL, Kochman RL, Geis GS, Rack EM, Deysach LG.
    Am J Gastroenterol; 1991 Dec 11; 86(12):1743-8. PubMed ID: 1962619
    [Abstract] [Full Text] [Related]

  • 39. Helicobacter pylori infection, ABO blood group, and effect of misoprostol on gastroduodenal mucosa in NSAID-treated patients with rheumatoid arthritis.
    Henriksson K, Uribe A, Sandstedt B, Nord CE.
    Dig Dis Sci; 1993 Sep 11; 38(9):1688-96. PubMed ID: 8359082
    [Abstract] [Full Text] [Related]

  • 40. Multicenter study of the safety/efficacy of misoprostol in the prevention and treatment of NSAID-induced gastroduodenal lesions.
    Grazioli I, Avossa M, Bogliolo A, Broggini M, Carcassi A, Carcassi U, Cecconami L, Ligniere GC, Colombo B, Consoli G.
    Clin Exp Rheumatol; 1993 Sep 11; 11(3):289-94. PubMed ID: 8353983
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.